Skip to main content

Site notifications

AusPAR: Nuvaxovid homologous booster

Device/Product Name
Nuvaxovid homologous booster
Active ingredients
SARS-CoV-2 rS vaccine with Matrix-M1 adjuvant
AusPAR Date
Published
Submission Number
PM-2022-00638-1-2
Submission Type
Major variation (change in dose regimen)
Decision
Approved for provisional registration

Help us improve the Therapeutic Goods Administration site